$USPH

U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations

U.S. Physical Therapy (NYSE: USPH) reported Q1 CY2026 earnings with revenue of $198.3 million, meeting analyst expectations, but a GAAP loss of $0.12 per share, significantly missing estimates. The company's adjusted EBITDA also fell below projections, and its operating margin decreased year-over-year. Despite these challenges, the company highlighted new initiatives aimed at improving efficiency and care, expecting them to bear fruit in the latter half of the year.

Original reporting
Published May 7, 2026, 7:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 7, 2026, 8:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations — source image
Decision brief

The 30-second read

$USPHNeutralMed
01

Why it matters

The earnings report suggests cautious trading; technical analysis indicates potential for short-term consolidation or minor decline.

02

Market read

The company's earnings provide insights into the healthcare services sector's current state, with limited broader market implications.

03

What to watch

Potential positive impact from upcoming healthcare policy changes or industry tailwinds that could offset short-term earnings concerns.

Timing: short-term (next 1-4 weeks)

Background

U.S. Physical Therapy reported Q1 CY2026 earnings with revenue meeting expectations but profits falling short, amid broader sector challenges.

Company-level read

Ticker impact

$USPHNeutralMedium confidence
Context

The company's Q1 CY2026 earnings report indicates mixed results with revenue meeting expectations but profitability falling short, which could influence short-term trading decisions.

Expected impact

Potential short-term sideways movement with slight downward bias due to earnings miss on profitability.

Evidence & confidence

Revenue met expectations, but profit decline and negative sentiment from earnings suggest limited upside in the immediate term.

Market effects

The healthcare services sector may experience cautious trading activity due to mixed earnings reports across similar companies.

Limited regional impact; effects are primarily company-specific.

Low; the news is primarily relevant to U.S.-based healthcare service providers.

Counterpoint

The company's initiatives to improve efficiency could lead to a turnaround in profitability in the coming quarters, presenting a buying opportunity for long-term investors.

Key entities

  • U.S. Physical Therapy

    A provider of outpatient physical therapy services in the U.S.

Related articles

$USPHMed

U S PHYSICAL THERAPY INC /NV (USPH): Results of Operations and Financial Condition

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 ex99-1.htm Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results,

$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

$WTRGMed

Trump administration to invest $3 billion in minerals projects to boost US defence supply chains

President Trump said the US will invest $3 billion in critical minerals and battery projects to expand domestic supply chains for national security. He announced Defence Department Office of Strategic Capital conditional loans totaling $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics, plus $58M Export-Import Bank loans. The plan also includes $100M in mining-school grants and $80M for three schools.

$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

$NVDAMed

Nvidia to invest up to US$3 billion in Stargate data centre developer Lancium: The Information

Nvidia plans to invest up to $3 billion in Lancium, the developer of the Stargate data center campus in Texas, The Information reported. Nvidia would invest $2 billion for about a 20% stake, with an additional $1 billion possible based on grid hookup thresholds. Lancium’s land and power portfolio has an enterprise value near $10 billion, and it may explore an IPO in 2027.

$USARMed

Is USA Rare Earth (USAR) Overvalued On Its DOE Funding And Tokenization Buzz?

Simply Wall St says USA Rare Earth (USAR) shares have rebounded after being selected by the U.S. Department of Energy for up to $19.3M in federal funding, pending final negotiations, for a pilot-scale rare earth separations project. The article cites mixed valuation views, with a “fair value” of $0.33 versus a DCF estimate of $83.09, and notes recent price returns.